Yaz Birth Control Lawsuit - Consumer Drug Report
Yaz and Yasmin blood clot risk higher than traditional birth control pills

It has been determined by Canada Health officials that Yaz and Yasmin blood risks are substantially higher than traditional birth control pills. On Monday, December 5, 2011, Health Canada announced that a review of the two Bayer birth control pills may increase blood clot risks by 1.5 to 3 times more than traditional birth control pills.

As a result of this increased risk, Health Canada decided to update labeling to warn health care officials of the dangers prior to prescribing the medication. Similarly to the results determined by the Food and Drug Administration, Health Canada states that users of newer birth control pills have a 75% higher risk of developing blood clots than women not taking birth control pills. It was also determined from the study that the risk of heart attack and stroke are double that of women taking traditional birth control pills.

On December 8, the FDA Advisory panel met to discuss the safety of Yaz and Yasmin. The advisory committee voted on the benefits of Yaz and concluded that the benefits outweighed the risks. However, the need for stronger warning labels was suggested by the committee.

Yaz was introduced in 2006 and quickly became the fastest growing birth control pill in the U.S. according to IMS Health, a company which tracks pharmaceutical sales. Yaz brought in revenues in 2009 of $781 million. However, due to emerging safety concerns, sales have dropped to $374 million making it the fourth most popular birth control pill.

Both Yaz and Yasmin are made with a new type of progestin known as drospirenone in conjunction with estrogen. Drospirenone was originally introduced in Yasmin by Berlex Laboratories, a unit of Bayer. Hundreds of women are currently filing Yasmin and Yaz lawsuits throughout the U.S. as a result of Bayer failing to adequately warn about the risks of blood clots.  Effects of Yaz cause victims to now suffer serious and life threatening injuries including stroke, pulmonary embolism, deep vein thrombosis, gallbladder disease and death.


About the Contributor

Related Posts